Latest News and Press Releases
Want to stay updated on the latest news?
-
New Delhi, June 10, 2024 (GLOBE NEWSWIRE) -- According to the latest research by Astute Analytica, the Cambodia beer market is estimated to attain a valuation of US$ 2,232.5 million by 2032, up from...
-
Technip Energies (PARIS :TE) et Mitsubishi Chemical Corporation, filiale du groupe Mitsubishi Chemical, ont annoncé l'obtention d'une licence pour une technologie améliorée d'alcool OXO, appelée 'OXO...
-
Chicago, June 10, 2024 (GLOBE NEWSWIRE) -- Electrosurgery market in terms of revenue was estimated to be worth $6.9 billion in 2024 and is poised to reach $9.4 billion by 2029, growing at a CAGR of...
-
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5...
-
OSE Immunotherapeutics et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation...
-
Leavenworth, Kansas, June 04, 2024 (GLOBE NEWSWIRE) -- Every organization has a fundamental purpose that drives its existence. Given this context, leaders shoulder the responsibility of...
-
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Four portfolio companies of Charlesbank Capital Partners—Action Behavior Centers, Hearthside Food Solutions, Park Place and Tecomet—have been named to...
-
Transformational acquisition expected to accelerate EBITDA margin expansionMRP to continue delivering services through existing operating companies and brandsKelly management to host live webcast on...
-
Boston, May 29, 2024 (GLOBE NEWSWIRE) -- A new report from The Bridgespan Group, “Boats for a Rising Tide: How Philanthropy Can Narrow the Racial Wealth Gap,” examines the drivers of and...
-
Novotech Announces MOU with Experienced Psychedelics Research Center at the 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston